RMP Summer Series: Genes & Proteins w/ the Patient at the Nucleus
Genes & Proteins with the Patient at the Nucleus: Building Level 1 Evidence for Prostate Cancer (Radio)therapy Speaker: Dr. Ale Berlin is a staff clinician-scientist radiation oncologist at the Princess Margaret Cancer Center – University of Toronto. He completed training in Chile, Israel, and Canada. His clinical practice focuses on the discovery and clinical evaluation of novel therapeutics capitalizing on genomic characterization genitourinary malignancies, and advanced molecular and MR imaging. Dr. Berlin is the PI of NRG GU010: two prospective RCTs investigating the use of clinicogenomic risk stratification for treatment individualization in men with localized prostate cancer. Dr. Berlin has also lead a clinical initiative quantifying the human and machine performance during the clinical deployment of an in-house developed AI radiotherapy planning method for prostate cancer. July 6, 2023 | Princess Margaret Cancer Centre | Radiation Medicine Program

RMP Summer Series: The Evolving Role of Genomic Biomarkers to Guide Mgmt of Ductal Carcinoma in Situ

How AI Cracked the Protein Folding Code and Won a Nobel Prize

RMP Summer Series: Advancing Personalized Medicine Approaches for Cervical Cancer

The most important lesson from 83,000 brain scans | Daniel Amen | TEDxOrangeCoast

Pharyngeal Residue - Webinar

Conan O’Brien Mocks Trump At Harvard Commencement | Crowd Erupts During Viral Speech

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Doctor Explains Why They're Terrified to Speak Out

Digital Asset Treasuries Under Pressure, IMF Warns of Tokenization Risks | Bloomberg Crypto 4/7/2026

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

The French Do Not Care About Work

RMP Summer Series: Genes in the Multiome of Madness

Death Is Not The End — Feynman Explains What Physics Says About Dying

Read The Korea Economic Daily in 30 Minutes | 05/27/2026🌞#MorningRoutine

Managing Risk Factors to Maintain Brain Health, March 2026

RASolute-302 with Daraxonrasib - Game Changer at ASCO 2026 in Pancreatic Cancer

Think Fast, Talk Smart: Communication Techniques

University of Toronto Echo Boot Camp Intro

Ivermectin to Treat Cancer? Get the FACTS

